Collplant ceo yehiel tal to moderate isbf's virtual event on biofabrication of microphysiological systems for drug discovery and screening

Rehovot, israel , april 25, 2022 /prnewswire/ -- collplant (nasdaq: clgn), a regenerative and aesthetics medicine company developing innovative technologies and products for tissue regeneration and organ manufacturing, today announced that ceo yehiel tal will moderate the international society for biofabrication's (isbf) virtual event on may 2 nd. mr. tal also serves as a board member of isbf.
CLGN Ratings Summary
CLGN Quant Ranking